WHO ICTRP trial
A real world study on the dosage and timing of hexapopal ethanolamine tablets…
ChiCTR2400094614 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400094614 |
|---|---|
| Public title | A real world study on the dosage and timing of hexapopal ethanolamine tablets for tumor-induced thrombocytopenia |
| Scientific title | A real world study on the dosage and timing of hexapopal ethanolamine tablets for tumor-induced thrombocytopenia |
| Primary sponsor | Hebei General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | tumor |
| Interventions | combination treatment group:None;high-dose monotherapy group:None;low-dose monotherapy group:None |
| Registration date | Dec 25, 2024 |
| Target size | combination treatment group:150;high-dose monotherapy group:150;low-dose… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: